1. |
Danaei G, Finucane MM, Lu Y, et al.National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980:systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants[J].Lancet, 2011, 378(9785):31-40.
|
2. |
Lazar MA.How obesity causes diabetes:not a tall tale[J].Science, 2005, 307(5708):373-375.
|
3. |
Picot J, Jones J, Colquitt JL, et al.The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity:a systematic review and economic evaluation[J].Health Technol Assess, 2009, 13(41):1-190, 215.
|
4. |
Liu Y, Zhou Y, Wang Y, et al.Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1[J].Obes Surg, 2011, 21(9):1424-1431.
|
5. |
Buchwald H, Estok R, Fahrbach K, et al.Weight and type 2 diabetes after bariatric surgery:systematic review and meta-anal-ysis[J].Am J Med, 2009, 122(3):248-256.e5.
|
6. |
Kashyap SR, Daud S, Kelly KR, et al.Acute effects of gastric bypass versus gastric restrictive surgery onβ-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes[J].Int J Obes, 2010, 34(3):462-471.
|
7. |
Cummings DE, Overduin J, Shannon MH, et al.Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery[J].Surg Obes Relat Dis, 2005, 1(3):358-368.
|
8. |
Cummings DE, Weigle DS, Frayo RS, et al.Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery[J].N Engl J Med, 2002, 346(21):1623-1630.
|
9. |
Gauna C, Meyler FM, Janssen JA, et al.Administration of acyl-ated ghrelin reduces insulin sensitivity, whereas the combinationof acylated plus unacylated ghrelin strongly improves insulin sensi-tivity[J].J Clin Endocrinol Metab, 2004, 89(10):5035-5042.
|
10. |
Faria G, Preto J, da Costa EL, et al.Acute improvement in insulin resistance after laparoscopic Roux-en-Y gastric bypass:is 3 days enough to correct insulin metabolism?[J].Obes Surg, 2013, 23(1):103-110.
|
11. |
Chai F, Wang Y, Zhou Y, et al.Adiponectin downregulates hy-perglycemia and reduces pancreatic islet apoptosis after Roux-en-Y gastric bypass surgery[J].Obes Surg, 2011, 21(6):768-773.
|
12. |
Durczynski A, Szymanski D, Nowicki M, et al.The impact of the repair of staple line dehiscence in post-RYGB patients on glucose homeostasis and gut hormones-a preliminary study[J].Endokrynol Pol, 2013, 64(1):7-12.
|
13. |
Sjöström L, Narbro K, Sjöström CD, et al.Effects of bariatric surgery on mortality in Swedish obese subjects[J].N Engl J Med, 2007, 357(8):741-752.
|
14. |
Cummings DE, Purnell JQ, Frayo RS, et al.A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans[J].Diabetes, 2001, 50(8):1714-1719.
|
15. |
Ariyasu H, Takaya K, Iwakura H, et al.Transgenic mice overex-pressing des-acyl ghrelin show small phenotype[J].Endocrino-logy, 2005, 146(1):355-364.
|
16. |
Sun Y, Butte NF, Garcia JM, et al.Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance[J].Endocrinology, 2008, 149(2):843-850.
|
17. |
Fung JN, Jeffery PL, Lee JD, et al.Silencing of ghrelin receptor expression inhibits endometrial cancer cell growth in vitro and in vivo[J].Am J Physiol Endocrinol Metab, 2013, 305(2):E305-E313.
|
18. |
Cheyuo C, Jacob A, Wang P.Ghrelin-mediated sympathoinhibition and suppression of inflammation in sepsis[J].Am J Physiol Endocrinol Metab, 2012, 302(3):E265-E272.
|
19. |
Vila G, Maier C, Riedl M, et al.Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans[J].J Clin Endocrinol Metab, 2007, 92(10):3930-3934.
|
20. |
Delgado M, Ganea D.Anti-inflammatory neuropeptides:a new class of endogenous immunoregulatory agents[J].Brain Behav Immun, 2008, 22(8):1146-1151.
|
21. |
Dixit VD, Schaffer EM, Pyle RS, et al.Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells[J].J Clin Invest, 2004, 114(1):57-66.
|
22. |
Zhang S, Zhang Q, Zhang L, et al.Expression of ghrelin and leptin during the development of type 2 diabetes mellitus in a rat model[J].Mol Med Rep, 2013, 7(1):223-228.
|
23. |
Cusi K, Maezono K, Osman A, et al.Insulin resistance differentially affects the PI3-kinase-and MAP kinase-mediated signaling in human muscle[J].J Clin Invest, 2000, 105(3):311-320.
|
24. |
Cantley LC.The phosphoinositide 3-kinase pathway[J].Science, 2002, 296(5573):1655-1657.
|
25. |
Zierath JR, Krook A, Wallberg-Henriksson H.Insulin action in skeletal muscle from patients with NIDDM[J].Mol Cell Biochem, 1998, 182(1-2):153-160.
|